A US pharmaceutical manufacturer running eight validated production lines faced a recurring compliance liability: maintenance-related FDA 483 observations in three consecutive inspection cycles. The root cause was not inadequate maintenance — it was inadequate documentation. Calibration records completed on paper and transcribed days later. Preventive maintenance schedules updated in spreadsheets disconnected from the shop floor. Equipment qualification status visible only to the document control team. That disconnect is what Oxmaint closes — connecting field execution to validated, auditable records at the point of work. Book a demo to see how Oxmaint structures FDA 21 CFR Part 11-compliant maintenance documentation for your production environment.
A mid-size pharmaceutical manufacturer with eight validated production lines eliminated maintenance-related FDA 483 findings by deploying Oxmaint as its validated CMMS. Critical outcomes: zero 483 observations at the first post-deployment FDA inspection, 98% PM compliance within 90 days, and audit documentation assembled in under 90 minutes versus the prior three-week manual process. This case study covers the documentation gaps that drove the compliance failure, the Oxmaint deployment approach, and the measurable outcomes at 6, 12, and 18 months post-deployment.
The Compliance Gap: What Three Consecutive 483 Cycles Revealed
Each FDA 483 observation carried a written response obligation, a CAPA commitment, and a follow-up verification requirement. None of the three cycles identified inadequate maintenance practices — all three identified inadequate documentation of maintenance practices. Book a demo to map your current documentation gaps against FDA 21 CFR Part 211 requirements.
Calibration activities were performed on schedule — but records were handwritten in the field and transcribed to the system-of-record hours or days after the activity. FDA investigators found 23 calibration records with a document date that did not match the instrument timestamp, triggering a data integrity observation under 21 CFR 211.68.
The PM schedule was maintained in a spreadsheet updated by the maintenance planner and not visible to production supervisors or QA. When investigators requested evidence that all scheduled PMs on validated equipment had been completed in the prior 12 months, the plant could not produce a consolidated, auditable PM completion log within the inspection window.
IQ/OQ/PQ qualification records were stored in document control — but the maintenance system had no link to qualification status. Following a corrective maintenance event on a tablet press, production resumed without a documented assessment of whether the repair required requalification. The gap between maintenance records and qualification status triggered a 21 CFR 211.68(b) observation.
Prior 483 responses committed to CAPA items with defined closure dates. At the next inspection, investigators found seven CAPA items past their committed closure date with no documented extension justification or escalation record — a pattern that elevated the inspection risk profile and contributed to a repeat observation classification.
Documentation Integrity, Not Just Documentation Volume
FDA investigators cite documentation that exists but cannot be retrieved, verified, or trusted — not documentation that was never created. Oxmaint closes the gap between what was done and what is provably documented. Book a demo to see how Oxmaint structures 21 CFR Part 11-compliant maintenance records for your facility.
Deployment Approach: From Paper Permits to Validated CMMS in Six Weeks
The deployment followed a structured sequence designed to achieve FDA audit readiness without disrupting ongoing GMP production — with no IT project, no validation consultant engagement beyond internal IQ/OQ execution, and no production downtime.
All GMP-critical equipment registered in Oxmaint's asset hierarchy — with qualification status, PM interval, calibration schedule, and regulatory classification (direct impact, indirect impact, no impact) assigned per asset. Existing PM procedures imported as digital templates. Equipment-specific LOTO isolation point checklists built from current isolation registers.
Oxmaint configured for Part 11 compliance — electronic signatures with role-based authorization, audit trail enabled on all record modifications, system access controls per user role. Technicians access work orders on mobile via QR-tagged equipment. Calibration readings and PM completion records captured at the instrument, not transcribed after the shift. Book a demo to see the Part 11 configuration workflow for your facility's validation scope.
Oxmaint compliance dashboard activated with PM completion rates, overdue calibration tasks, CAPA closure status, and requalification flags visible to maintenance, QA, and plant management. Audit documentation export tested against FDA inspection request format — full 12-month PM and calibration history produced in under 90 minutes. Internal pre-inspection audit review passed without documentation gaps.
Measured Outcomes at 6, 12, and 18 Months
Outcomes tracked against the three operational metrics that drove the original 483 risk: PM compliance rate, calibration record integrity, and CAPA closure velocity.
From Three Consecutive 483 Cycles to Zero — in One Inspection
The documentation gap between field execution and auditable record is the leading driver of maintenance-related 483 findings in pharmaceutical manufacturing. Oxmaint closes that gap at the point of work. Book a demo to see the compliance dashboard configured for your validated equipment scope.
Oxmaint Pharma Compliance Capabilities
Electronic signatures with role-based authorization, immutable audit trail on all record modifications, and system access controls configured per FDA 21 CFR Part 11 requirements — validated out-of-the-box.
Calibration intervals per instrument, automated due-date alerts, and readings captured at the instrument with locked system timestamp — eliminating transcription latency and data integrity risk under 21 CFR 211.68.
IQ/OQ/PQ status linked to every work order — corrective maintenance on qualified equipment automatically flags a requalification assessment requirement before the work order can be closed.
CAPA items tracked against committed FDA response dates with automated escalation at 75% and 100% of deadline. Extension requests require documented authorization — no silent overdue status.
Full 12-month PM completion history, calibration records, CAPA closure evidence, and work order audit trail exportable in under 90 minutes — formatted for FDA inspection request response without manual assembly.
PM compliance rates, overdue calibrations, CAPA closure status, and requalification flags visible across all production sites in a single QA and maintenance management view — with role-appropriate data scope per user.
Frequently Asked Questions
Close the Documentation Gap Before the Next FDA Inspection
21 CFR Part 11-compliant maintenance records, calibration schedule management, qualification status linking, and CAPA lifecycle tracking — all live in Oxmaint within six weeks, no IT project required. Book a demo with your VP of Quality or VP of Operations and see the full compliance workflow configured for your production environment.
